Worldwide Biotech & Pharmaceutical CO - FORM 10-K - EX-32 - EXHIBIT 32 - March 31, 2010

Attached files

file filename
10-K - WWBP 10-K 12/31/2009 - Worldwide Biotech & Pharmaceutical COform10-k.htm
EX-21 - EXHIBIT 21 - Worldwide Biotech & Pharmaceutical COex21.htm
EX-31.1 - EXHIBIT 31.1 - Worldwide Biotech & Pharmaceutical COex31_1.htm
EX-31.2 - EXHIBIT 31.2 - Worldwide Biotech & Pharmaceutical COex31_2.htm
 
 
EXHIBIT 32


STATEMENT REQUIRED BY 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002


In connection with the Annual Report on Form 10-K of Worldwide Biotech & Pharmaceutical Company (the "Company") for the year ended December 31, 2009, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Wenxia Guo, Chief Executive Officer, and Peng Wang, Chief Financial Officer of the Company, individually certify that:

·      the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

·      information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company on the dates and for the periods presented.



/s/  Wenxia Guo
Wenxia Guo
Chief Executive Officer
 
Dated:  March 31, 2010
 
 
 
/s/ Peng Wang
Peng Wang
Chief Financial Officer
 
Dated:  March 31, 2010


Worldwide Biotech & Pharmaceutical CO Reports